|
Subtype/Strain
|
Product Name
|
Description
|
Catalogue #
|
| SARS-CoV-2 |
Full-length Spike Protein, HEK293 |
C-terminal His-tag |
SCV2-S-050P |
| (COVID19) |
S1 Protein, HEK293 |
C-terminal His-tag |
SCV2-S1-150P |
|
Spike S1(D614G) Protein, HEK293 |
C-terminal His-tag |
SCV2-S1-614G |
|
Spike S1(UK Variant B.1.1.7) Protein, HEK293 |
C-terminal His-tag |
SCV2-S1-UKp |
|
Spike S1(South Africa Variant B.1.351) Protein, HEK293 |
C-terminal His-tag |
SCV2-S1-SAp |
|
Spike RBD (aa 319-541) protein, HEK293 |
C-terminal His-tag |
SCV2-RBD-050P |
| |
Spike RBD (aa 309-528) protein, HEK293 |
C-terminal hFc-tag |
SCV2-RBD-060P |
|
Spike RBD protein (Omicron variant B.1.1.529), HEK293 |
His-tag |
SCV2-RBD-OmicronP |
|
Spike RBD protein (Omicron XBB subtype), HEK293 |
His-tag |
SCV2-RBD-XBBp |
|
Spike RBD protein (UK variant B.1.1.7), HEK293 |
His-tag |
SCV2-RBD-UK50P |
|
Spike RBD protein (South Africa variant B.1.351), HEK293 |
His-tag |
SCV2-RBD-SA50P |
|
Spike RBD protein (Brazil variant P1), HEK293 |
His-tag |
SCV2-RBD-BR50P |
|
Spike RBD protein (Delta variant B.1.617.2), HEK293 |
His-tag |
SCV2-RBD-IN2P |
|
Spike RBD protein (Delta plus variant B.1.617.2.1 or AY.1), HEK293 |
His-tag |
SCV2-RBD-Delta2P |
|
Spike RBD protein (E484K mutation), HEK293 |
His-tag |
SCV2-RBD-E484Kp |
|
Spike RBD protein (L452R mutation), HEK293 |
His-tag |
SCV2-RBD-L452Rp |
|
Spike RBD protein (S477N mutation), HEK293 |
His-tag |
SCV2-RBD-S477Np |
|
Membrane protein (M), E. coli |
N-terminal His-tag |
SCV2-M-050P |
|
|
Envelope protein (E), E. coli
|
N-terminal His-SUMO tag
|
SCV2-E-050P |
|
Nucleocapsid protein, E. coli |
C-terminal His-tag |
SCV2-NP-050P |
|
Anti-Spike protein neutralization antibody |
Human IgG |
SCV2-SA-11m |
|
Anti-Spike protein neutralization antibody - reacts with spikes of many major variants |
Human IgG |
SCV2-S-400m |
|
Anti-SARS-CoV-2, Biosimilar of Therapeutic Antibody - reacts with spikes of many major variants |
Human IgG |
SCV2-BeMab |
|
Anti-Spike protein polyclonal antibody - reacts with spikes of many major variants |
Rabbit IgG |
SCV2-SA-200 |
|
Anti-Spike protein polyclonal antibody - reacts with spikes of all major variants (Alpha, Beta, Delta, Omicron) |
Rabbit IgG |
SCV2-S-300 |
|
Anti-Spike protein (SARS-CoV-2/South Africa Variant) polyclonal antibody |
Rabbit Serum |
SCV2-SA-255 |
|
Anti-Spike protein polyclonal antibody |
Rabbit IgG |
SCV2-S-100 |
|
Anti-Spike RBD mouse monoclonal antibody |
mouse IgG1 |
SCV2-RBD-01m |
|
Anti-Spike RBD human monoclonal antibody |
Human IgG1 |
SCV2-RBD-100m |
|
Anti-Spike RBD neutralizing antibody |
Human IgG |
SCV2-RBD-200m |
|
Anti-Spike RBD human neutralization antibody |
Human IgG1 |
SCV2-RBD-h12 |
|
Anti-Spike RBD human monoclonal antibody |
Human IgG1 |
SCV2-RBD-h26 |
|
Anti-Spike S1 mouse monoclonal antibody |
mouse IgG1 |
SCV2-S1-21m |
|
Anti-Spike S1 human monoclonal antibody |
Human IgG1 |
SCV2-S1-h22 |
|
Anti-Spike S1 human monoclonal antibody |
Human IgM |
SCV2-S1-h25 |
|
Anti-SARS-CoV-2 S2 mouse monoclonal antibody |
Mouse IgG1 |
SCV2-S2-001 |
|
Anti-NP polyclonal antibody |
Rabbit IgG |
SCV2-NP-100 |
|
Anti-M (aa 159-186) polyclonal antibody |
Rabbit IgG |
NCV-M-005 |
|
Anti-Membrane Protein Antibody |
Rabbit IgG |
SCV2-M-100 |
|
Anti-Envelope Protein (SARS-CoV-2) Antibody |
Rabbit IgG |
SCV2-E-100 |
|
|
SARS-CoV-2 Pseudoviral Particles (pseudotyped with the original spike, Wuhan-Hu-1), 1 vial x 5mL
|
Replication-deficient pseudovirus
|
SCV2-PsV-001
|
|
|
SARS-CoV-2 Pseudoviral Particles (pseudotyped with the original spike Wuhan-Hu-1), 5 vials x 1mL
|
Replication-deficient pseudovirus
|
SCV2-PsV-0011
|
|
|
SARS-CoV-2 Pseudoviral Particles (pseudotyped with the Omicron (B.1.1.529) variant spike)
|
Replication-deficient pseudovirus
|
SCV2-PsV-Omicron
|
|
SARS-CoV-2 Pseudoviral Particles (pseudotyped with the Omicron B.2 variant spike) |
Replication-deficient pseudovirus |
SCV2-PsV-OmiBA2 |
|
SARS-CoV-2 Pseudoviral Particles (pseudotyped with the Omicron B.2.75 variant spike) |
Replication-deficient pseudovirus |
SCV2-PsV-BA2.75 |
|
SARS-CoV-2 Pseudoviral Particles (pseudotyped with the Omicron B.2.12.1 variant spike) |
Replication-deficient pseudovirus |
SCV2-PsV-BA2.12.1 |
|
SARS-CoV-2 Pseudoviral Particles (pseudotyped with the Omicron BQ.1 variant spike) |
Replication-deficient pseudovirus |
SCV2-PsV-BQ1 |
|
SARS-CoV-2 Pseudoviral Particles (pseudotyped with the Omicron BQ.1.1 variant spike) |
Replication-deficient pseudovirus |
SCV2-PsV-BQ1.1 |
|
SARS-CoV-2 Pseudoviral Particles (pseudotyped with the Omicron CH.1.1 variant spike) |
Replication-deficient pseudovirus |
SCV2-PsV-CH1.1 |
|
SARS-CoV-2 Pseudoviral Particles (pseudotyped with the Omicron CA.3.1 variant spike) |
Replication-deficient pseudovirus |
SCV2-PsV-CA3.1 |
|
|
SARS-CoV-2 Pseudoviral Particles (pseudotyped with the Omicron BA.2.86 variant spike)
|
Replication-deficient pseudovirus
|
SCV2-PsV-BA2.86
|
|
|
SARS-CoV-2 Pseudoviral Particles (pseudotyped with the Omicron BA.2.87.1 variant spike)
|
Replication-deficient pseudovirus
|
SCV2-PsV-BA2.87.1
|
|
|
SARS-CoV-2 Pseudoviral Particles (pseudotyped with the Omicron BA.4 variant spike)
|
Replication-deficient pseudovirus
|
SCV2-PsV-BA4
|
|
|
SARS-CoV-2 Pseudoviral Particles (pseudotyped with the Omicron BA.4.7 variant spike)
|
Replication-deficient pseudovirus
|
SCV2-PsV-BA4.7
|
|
|
SARS-CoV-2 Pseudoviral Particles (pseudotyped with the Omicron BA.5 variant spike)
|
Replication-deficient pseudovirus
|
SCV2-PsV-BA5
|
|
|
SARS-CoV-2 Pseudoviral Particles (pseudotyped with the Omicron BA.5.9 variant spike)
|
Replication-deficient pseudovirus
|
SCV2-PsV-BA5.9
|
|
|
SARS-CoV-2 Pseudoviral Particles (pseudotyped with the Omicron BF.1 variant spike)
|
Replication-deficient pseudovirus
|
SCV2-PsV-BF7
|
|
|
SARS-CoV-2 Pseudoviral Particles (pseudotyped with the Omicron BJ.1 variant spike)
|
Replication-deficient pseudovirus
|
SCV2-PsV-BJ1
|
|
|
SARS-CoV-2 Pseudoviral Particles (pseudotyped with the Omicron FL.1.5.1 variant spike)
|
Replication-deficient pseudovirus
|
SCV2-PsV-FL1.5.1
|
|
SARS-CoV-2 Pseudoviral Particles (pseudotyped with the Omicron XBB variant spike) |
Replication-deficient pseudovirus |
SCV2-PsV-XBB |
|
|
SARS-CoV-2 Pseudoviral Particles (pseudotyped with the Omicron XBB.1.5 variant spike)
|
Replication-deficient pseudovirus
|
SCV2-PsV-XBB1.5
|
|
|
SARS-CoV-2 Pseudoviral Particles (pseudotyped with the Omicron XBB.1.16 variant spike)
|
Replication-deficient pseudovirus
|
SCV2-PsV-XBB1.16
|
|
|
SARS-CoV-2 Pseudoviral Particles (pseudotyped with the Omicron XBB.1.16.6 variant spike)
|
Replication-deficient pseudovirus
|
SCV2-PsV-XBB1.16.6
|
|
|
SARS-CoV-2 Pseudoviral Particles (pseudotyped with the Omicron EG.5.1 variant spike)
|
Replication-deficient pseudovirus
|
SCV2-PsV-EG5.1
|
|
|
SARS-CoV-2 Pseudoviral Particles (pseudotyped with the Omicron HV.1 variant spike)
|
Replication-deficient pseudovirus
|
SCV2-PsV-HV1
|
|
|
SARS-CoV-2 Pseudoviral Particles (pseudotyped with the Omicron JN.1 variant spike)
|
Replication-deficient pseudovirus
|
SCV2-PsV-JN.1
|
|
|
SARS-CoV-2 Pseudoviral Particles (pseudotyped with the Omicron JN.1.13.1 variant spike)
|
Replication-deficient pseudovirus
|
SCV2-PsV-JN1.13.1
|
|
|
SARS-CoV-2 Pseudoviral Particles (pseudotyped with the Omicron JN.1.18 variant spike)
|
Replication-deficient pseudovirus
|
SCV2-PsV-JN1.18
|
|
|
SARS-CoV-2 Pseudoviral Particles (pseudotyped with the Omicron JN.1.7 variant spike)
|
Replication-deficient pseudovirus
|
SCV2-PsV-JN1.7
|
|
|
SARS-CoV-2 Pseudoviral Particles (pseudotyped with the Omicron JN.4 variant spike)
|
Replication-deficient pseudovirus
|
SCV2-PsV-JN.4
|
|
|
SARS-CoV-2 Pseudoviral Particles (pseudotyped with the Omicron KP.1.1 variant spike)
|
Replication-deficient pseudovirus
|
SCV2-PsV-KP1.1
|
|
|
SARS-CoV-2 Pseudoviral Particles (pseudotyped with the Omicron KP.2 variant spike)
|
Replication-deficient pseudovirus
|
SCV2-PsV-KP.2
|
|
|
SARS-CoV-2 Pseudoviral Particles (pseudotyped with the Omicron KQ.1 variant spike)
|
Replication-deficient pseudovirus
|
SCV2-PsV-KQ.1
|
|
|
SARS-CoV-2 Pseudoviral Particles (pseudotyped with the Omicron KZ.1.1.1 variant spike)
|
Replication-deficient pseudovirus
|
SCV2-PsV-KZ.1.1.1
|
|
|
SARS-CoV-2 Pseudoviral Particles (pseudotyped with the Omicron LB.1 variant spike)
|
Replication-deficient pseudovirus
|
SCV2-PsV-LB1
|
|
SARS-CoV-2 Pseudoviral Particles (pseudotyped with the Omicron LF.7 variant spike) |
Replication-deficient pseudovirus |
SCV2-PsV-LF7 |
|
SARS-CoV-2 Pseudoviral Particles (pseudotyped with the Omicron LP.8.1 variant spike) |
Replication-deficient pseudovirus |
SCV2-PsV-LP.8.1 |
|
SARS-CoV-2 Pseudoviral Particles (pseudotyped with the Omicron XBB.2.3 variant spike) |
Replication-deficient pseudovirus |
SCV2-PsV-XBB2.3 |
|
SARS-CoV-2 Pseudoviral Particles (pseudotyped with the Omicron XBF variant spike) |
Replication-deficient pseudovirus |
SCV2-PsV-XBF |
|
SARS-CoV-2 Pseudoviral Particles (pseudotyped with the Omicron XEC variant spike) |
Replication-deficient pseudovirus |
SCV2-PsV-XEC |
|
|
SARS-CoV-2 Pseudoviral Particles (pseudotyped with the CM.2 variant spike)
|
Replication-deficient pseudovirus
|
SCV2-PsV-CM2
|
|
|
SARS-CoV-2 Pseudoviral Particles (pseudotyped with the Deltacron variant spike)
|
Replication-deficient pseudovirus
|
SCV2-PsV-Deltacron
|
|
|
SARS-CoV-2 Pseudoviral Particles (pseudotyped with the Alpha (UK B.1.1.7) variant spike)
|
Replication-deficient pseudovirus
|
SCV2-PsV-UK
|
|
|
SARS-CoV-2 Pseudoviral Particles (pseudotyped with the Gamma (Brazil P.1) variant spike)
|
Replication-deficient pseudovirus
|
SCV2-PsV-BR
|
|
|
SARS-CoV-2 Pseudoviral Particles [pseudotyped with the Beta (South Africa B.1.351) variant spike]
|
Replication-deficient pseudovirus
|
SCV2-PsV-SA
|
|
|
SARS-CoV-2 Pseudoviral Particles (pseudotyped with the Indian B.1.617 variant spike)
|
Replication-deficient pseudovirus
|
SCV2-PsV-IN
|
|
|
SARS-CoV-2 Pseudoviral Particles [pseudotyped with the Delta (Indian B.1.617.2) variant spike]
|
Replication-deficient pseudovirus
|
SCV2-PsV-Delta
|
|
|
SARS-CoV-2 Pseudoviral Particles [pseudotyped with the Lambda (Peru C.37) variant spike]
|
Replication-deficient pseudovirus
|
SCV2-PsV-Lambda
|
|
|
SARS-CoV-2 Pseudoviral Particles (pseudotyped with the 614G variant spike)
|
Replication-deficient pseudovirus
|
SCV2-PsV-614G
|
|
|
SARS-CoV-2 Pseudoviral Particles (pseudotyped with the A222V-D614G variant spike)
|
Replication-deficient pseudovirus
|
SCV2-PsV-222V
|
|
|
SARS-CoV-2 Pseudoviral Particles (pseudotyped with the Y453F-D614G variant spike)
|
Replication-deficient pseudovirus
|
SCV2-PsV-453F
|
|
|
SARS-CoV-2 Pseudoviral Particles (pseudotyped with the N501Y-D614G variant spike)
|
Replication-deficient pseudovirus
|
SCV2-PsV-501Y
|
|
|
MLV Pseudoviral Particles, negative control
|
Replication-deficient pseudovirus
|
PsV-001
|
|
|
Recombinant human Angiotensin-Converting Enzyme 2 (hACE2) protein
|
Full length, no tag
|
hACE2-050P
|
|
|
Anti-ACE2 mouse monoclonal antibody
|
Mouse IgG
|
ACE2-MAb11
|
|
|
Human Angiotensin-Converting Enzyme 2 (hACE2) Stable Cell Line. with GFP reporter
|
HEK293-ACE2 stable cell line
|
CL-hACE2-001
|
|
|
Human Angiotensin-Converting Enzyme 2 (hACE2) Stable Cell Line
|
HEK293-ACE2 stable cell line
|
CL-hACE2-002
|
|
|
Human Neuropilin-1 (NRP-1) Stable Cell Line
|
HEK293-NRP1-ACE2 stable cell line
|
CL-NRP1-001
|
|
|
Human Angiotensin II Receptor Type 1 (AGTR-1, AT1R) Stable Cell Line
|
HEK293-AT1R stable cell line
|
CL-AT1R-001
|
|
|
Human Transmembrane Protease, Serine 2 (TMPRSS-2) Stable Cell Line |
HEK293-TMPRSS2-ACE2 stable cell line
|
CL-TMPRSS2-001
|
|
SARS-CoV
|
Spike protein (amino acid 1-1190), HEK293 cells
|
C-terminal his-tag
|
SS-001-005P
|
|
|
Spike RBD Domain of SARS-CoV, HEK293 cells
|
C-terminal his-tag
|
SCV-RBD-035P
|
|
|
Anti-Spike (SARS-CoV) polyclonal antibody
|
Rabbit IgG
|
SS-001-0100
|
|
|
Anti-E (SARS-CoV) polyclonal antibody
|
Rabbit IgG
|
SS-005-0100
|
|
|
Anti-NP (SARS-CoV) polyclonal antibody
|
Rabbit IgG
|
SS-006-0100
|
|
|
Anti-Spike (aa 19-48)(SARS-CoV)
|
Rabbit IgG
|
SCV-S-001
|
|
|
Anti-Spike (aa 278-312)(SARS-CoV) polyclonal antibody
|
Rabbit IgG
|
SCV-S-005
|
|
|
Anti-Spike (aa 368-419)(SARS-CoV) polyclonal antibody
|
Rabbit IgG
|
SCV-S-006
|
|
|
Anti-Spike (aa 450-479)(SARS-CoV) polyclonal antibody
|
Rabbit IgG
|
SCV-S-007
|
|
|
Anti-E (aa 48-76)(SARS-CoV) polyclonal antibody
|
Rabbit IgG
|
SCV-E-001
|
|
|
Anti-M (aa 4-26)(SARS-CoV) polyclonal antibody
|
Rabbit IgG
|
SCV-M-001
|
|
|
Anti-M (aa 132-161)(SARS-CoV) polyclonal antibody
|
Rabbit IgG
|
SCV-M-002
|
|
|
Anti-M (aa 158-185) polyclonal antibody
|
Rabbit IgG
|
NCV-M-005
|
|
|
SARS Pseudoviral Particles (pseudotyped with the SARS spike)
|
Replication-deficient pseudovirus
|
SCV1-PsV-003
|
|
|
cADP-Ribose Assay Kit (Fluorescence)
|
Assay Kit
|
CA-CADP10
|
|
MERS-CoV
|
MERS-CoV Spike S1 Protein (aa 18-725)
|
C-terminal his-tag
|
MERS-S1-005P
|
|
|
MERS-CoV Spike RBD Protein (aa 367-588)
|
C-terminal his-tag
|
MERS-RBD-005P
|
|
|
Anti-spike (MERS-CoV) antibody, rabbit IgG
|
Rabbit IgG
|
MERS-S1-015
|
|
|
Anti-spike (MERS-CoV) antibody, rabbit anti-serum
|
Rabbit serum
|
MERS-S1-020
|
|
|
Anti-S1 (MERS-CoV/HCoV-EMC/2012) Monoclonal Antibody
|
Mouse IgG1
|
MERS-S1-001
|
|
|
Anti-S1 (MERS-CoV/HCoV-EMC/2012) Monoclonal Antibody
|
Mouse IgG1
|
MERS-S1-005
|
|
|
Anti-S1 (MERS-CoV/HCoV-EMC/2012) Monoclonal Antibody
|
Mouse IgG1
|
MERS-S1-006
|
|
|
MERS Pseudoviral Particles (pseudotyped with MERS spike)
|
Replication-deficient pseudovirus
|
MERS-PsV-001
|
|
|
|
|
|
|
Other Coronavirus
|
Anti-Spike (HCoV-HKU1) Rabbit Polyclonal Antibody
|
Rabbit IgG
|
HKU1-S-100
|
|
|
|
|
|
|
|
|
|
|